查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1265648

营养基因学的全球市场

Nutrigenomics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

营养基因学的全球市场在2030年前将达到25亿美元

在COVID-19后改变的商务环境中，2022年7亿1,500万美元的营养基因学的全球市场，在2022年～2030年预计将以年复合成长率17％增长，在2030年前将达到25亿美元。本报告所分析之市场区隔之一的试剂·套件将以年复合成长率18.1％增长，到分析期间结束时将达到18亿美元。考虑疫情后的復苏，服务领域今后8年的年复合成长率将修正为14.7％。

美国市场估算为2亿920万美元，中国则将以年复合成长率16％的速度成长

美国的营养基因学市场在2022年估算为2亿920万美元。作为世界第2大经济大国的中国，在2022年～2030年年复合成长率预计将为16％，在2030年前将达到4亿2,190万美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年预计将各以14.7％和13.8％的速度成长。在欧洲市场中，德国以年复合成长率10.8％成长。

调查对象企业范例

  • BASF SE
  • Cell-Logic
  • Cura Integrative Medicine
  • Geneus Health, LLC
  • Genova Diagnostics
  • GX Sciences, Inc.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Orig3n
  • Prenetics Limited
  • Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
  • The Gene Box
  • Unilever
  • Xcode Life

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP22397

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nutrigenomics Market to Reach $2.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nutrigenomics estimated at US$715 Million in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at aCAGR of 17% over the period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 18.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 14.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $209.2 Million, While China is Forecast to Grow at 16% CAGR

The Nutrigenomics market in the U.S. is estimated at US$209.2 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$421.9 Million by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.7% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 33 Featured) -

  • BASF SE
  • Cell-Logic
  • Cura Integrative Medicine
  • Geneus Health, LLC
  • Genova Diagnostics
  • GX Sciences, Inc.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Orig3n
  • Prenetics Limited
  • Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
  • The Gene Box
  • Unilever
  • Xcode Life

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Nutrigenomics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Nutrigenomics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: China 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: France 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION